Katherine Lammers
Obstetrics & Gynecology · Rochester, NYNPI 1760481675
Payments from drug & device makers
Across 69 payments — averaging $19.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$222
- AbbVie$187
- Sumitomo Pharma America, Inc.$124
- Novo Nordisk$106
- Exeltis, USA Inc.$106
- Biogen$85
- plus $521 from 18 others
What the payments were for
- Food & beverage$1,30597%
- Education$463%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 13 | $222 |
| AbbVie(2 entities) | 10 | $187 |
| Sumitomo Pharma America, Inc. | 5 | $124 |
| Novo Nordisk | 6 | $106 |
| Exeltis, USA Inc. | 4 | $106 |
| Biogen | 3 | $85 |
| Coopersurgical, Inc. | 4 | $76 |
| Bayer | 3 | $53 |
| AMAG Pharmaceuticals, Inc. | 2 | $46 |
| Therapeuticsmd, Inc. | 2 | $40 |
| Millicent US Inc | 2 | $37 |
| Organon | 1 | $28 |
| Lupin Inc. | 2 | $28 |
| Avion Pharmaceuticals | 2 | $27 |
| Urovant Sciences Inc | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| Agile Therapeutics, Inc. | 1 | $20 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Merck | 1 | $16 |
| Mission Pharmacal Company | 1 | $16 |
| Smith+Nephew | 1 | $16 |
| Coloplast | 1 | $15 |
How this compares
$1,351 in reported general payments places this provider in the 75th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 19 | $1,040 |
| DottiEstradiol | 12 | $590 |
| Clobetasol EmollientClobetasol Propionate/Emoll | 12 | $492 |
| ValacyclovirValacyclovir Hcl | 11 | $383 |
| Nystatin | 29 | $342 |
| Alendronate Sodium | 33 | $323 |
| ApriDesogestrel-Ethinyl Estradiol | 12 | $197 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $120 |
| Raloxifene Hcl | 12 | $44 |
| Fluconazole | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Rochester
- Loralei ThornburgRochester$33K
- Marina FrimerBronx$8.5M
- Nicole NevadunskyBronx$2.5M
- Jin Hee KimNew York$1M
- Carolyn WesthoffNew York$935K
- Mary PolanNew York$862K
- Jessica AtrioBronx$752K
- Mark MartensAuburn$561K
- Steven GoldsteinNew York$557K
- Sharifa FaziliClarence$430K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.